A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial

Mona Bafadhel; Neil Barnes; Stephen C. Bourke; Chris Compton; Gerard J. Criner; Mark T. Dransfield; David M.G. Halpin; Mei Lan K. Han; Benjamin Hartley; C. Elaine Jones; Peter Lange; Sally Lettis; David A. Lipson; David A. Lomas; Neil Martin; Fernando J. Martinez; Robert Wise; Dave Singh

doi:10.1183/13993003.04522-2020

A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial

Mona Bafadhel, Neil Barnes, Stephen C. Bourke, Chris Compton, Gerard J. Criner, Mark T. Dransfield, David M.G. Halpin, Mei Lan K. Han, Benjamin Hartley, C. Elaine Jones, Peter Lange, Sally Lettis, David A. Lipson, David A. Lomas, Neil Martin, Fernando J. Martinez, Robert Wise, Dave Singh

School of Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Article number	2004522
Journal	European Respiratory Journal
Volume	58
Issue number	3
DOIs	https://doi.org/10.1183/13993003.04522-2020
State	Published - Sep 1 2021

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1183/13993003.04522-2020

Cite this

Bafadhel, M., Barnes, N., Bourke, S. C., Compton, C., Criner, G. J., Dransfield, M. T., Halpin, D. M. G., Han, M. L. K., Hartley, B., Jones, C. E., Lange, P., Lettis, S., Lipson, D. A., Lomas, D. A., Martin, N., Martinez, F. J., Wise, R., & Singh, D. (2021). A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial. European Respiratory Journal, 58(3), [2004522]. https://doi.org/10.1183/13993003.04522-2020

Bafadhel, M, Barnes, N, Bourke, SC, Compton, C, Criner, GJ, Dransfield, MT, Halpin, DMG, Han, MLK, Hartley, B, Jones, CE, Lange, P, Lettis, S, Lipson, DA, Lomas, DA, Martin, N, Martinez, FJ, Wise, R & Singh, D 2021, 'A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial', European Respiratory Journal, vol. 58, no. 3, 2004522. https://doi.org/10.1183/13993003.04522-2020

@article{fdc7577463b246c89e56ff77a0318f76,

title = "A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial",

author = "Mona Bafadhel and Neil Barnes and Bourke, {Stephen C.} and Chris Compton and Criner, {Gerard J.} and Dransfield, {Mark T.} and Halpin, {David M.G.} and Han, {Mei Lan K.} and Benjamin Hartley and Jones, {C. Elaine} and Peter Lange and Sally Lettis and Lipson, {David A.} and Lomas, {David A.} and Neil Martin and Martinez, {Fernando J.} and Robert Wise and Dave Singh",

note = "Funding Information: Acknowledgements: Editorial support (in the form of writing assistance, assembling figures, collating author comments, grammatical editing and referencing) was provided by Eloise Morecroft and Katie Baker, at Fishawack Indicia Ltd, UK, and was funded by GSK. D. Singh is supported by the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC). D.A. Lomas is supported by the National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC) and is an NIHR Senior Investigator. Funding Information: Support statement: This study was funded by GlaxoSmithKline (GSK; CTT116855; Clinicaltrials.gov identifier: NCT02164513). Funding information for this article has been deposited with the Crossref Funder Registry.",

year = "2021",

month = sep,

day = "1",

doi = "10.1183/13993003.04522-2020",

language = "English (US)",

volume = "58",

journal = "European Respiratory Journal, Supplement",

issn = "0903-1936",

publisher = "European Respiratory Society",

number = "3",

}

TY - JOUR

T1 - A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial

AU - Bafadhel, Mona

AU - Barnes, Neil

AU - Bourke, Stephen C.

AU - Compton, Chris

AU - Criner, Gerard J.

AU - Dransfield, Mark T.

AU - Halpin, David M.G.

AU - Han, Mei Lan K.

AU - Hartley, Benjamin

AU - Jones, C. Elaine

AU - Lange, Peter

AU - Lettis, Sally

AU - Lipson, David A.

AU - Lomas, David A.

AU - Martin, Neil

AU - Martinez, Fernando J.

AU - Wise, Robert

AU - Singh, Dave

N1 - Funding Information: Acknowledgements: Editorial support (in the form of writing assistance, assembling figures, collating author comments, grammatical editing and referencing) was provided by Eloise Morecroft and Katie Baker, at Fishawack Indicia Ltd, UK, and was funded by GSK. D. Singh is supported by the National Institute for Health Research (NIHR) Manchester Biomedical Research Centre (BRC). D.A. Lomas is supported by the National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC) and is an NIHR Senior Investigator. Funding Information: Support statement: This study was funded by GlaxoSmithKline (GSK; CTT116855; Clinicaltrials.gov identifier: NCT02164513). Funding information for this article has been deposited with the Crossref Funder Registry.

PY - 2021/9/1

Y1 - 2021/9/1

UR - http://www.scopus.com/inward/record.url?scp=85116769857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85116769857&partnerID=8YFLogxK

U2 - 10.1183/13993003.04522-2020

DO - 10.1183/13993003.04522-2020

M3 - Letter

C2 - 34385263

AN - SCOPUS:85116769857

SN - 0903-1936

VL - 58

JO - European Respiratory Journal, Supplement

JF - European Respiratory Journal, Supplement

IS - 3

M1 - 2004522

ER -

A single blood eosinophil count measurement is as good as two for prediction of ICS treatment response in the IMPACT trial

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this